These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 29476216)

  • 1. Late gadolinium enhancement of colorectal liver metastases post-chemotherapy is associated with tumour fibrosis and overall survival post-hepatectomy.
    Cheung HMC; Karanicolas PJ; Hsieh E; Coburn N; Maraj T; Kim JK; Elhakim H; Haider MA; Law C; Milot L
    Eur Radiol; 2018 Aug; 28(8):3505-3512. PubMed ID: 29476216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late gadolinium MRI enhancement of colorectal liver metastases is associated with overall survival among nonsurgical patients.
    Cheung HMC; Kim JK; Hudson J; Coburn N; Karanicolas PJ; Law C; Milot L
    Eur Radiol; 2019 Jul; 29(7):3901-3907. PubMed ID: 30937587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed tumour enhancement on gadoxetate-enhanced MRI is associated with overall survival in patients with colorectal liver metastases.
    Cheung HMC; Karanicolas PJ; Coburn N; Seth V; Law C; Milot L
    Eur Radiol; 2019 Feb; 29(2):1032-1038. PubMed ID: 29992388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor enhancement of colorectal liver metastases on preoperative gadobutrol-enhanced MRI at 5 minutes post-contrast injection is associated with overall survival post-hepatectomy.
    Cheung HMC; Karanicolas PJ; Coburn N; Law C; Milot L
    Quant Imaging Med Surg; 2019 Feb; 9(2):312-317. PubMed ID: 30976555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late Gadolinium Hyperintensity of Suspected Colorectal Liver Metastases on Gadofosveset-Enhanced Magnetic Resonance Imaging: A Predictor of Benignity and a Potential Problem-Solving Tool.
    Cheung HMC; Karanicolas PJ; Coburn N; Law C; Milot L
    Can Assoc Radiol J; 2019 Aug; 70(3):239-245. PubMed ID: 31272725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3T diffusion-weighted MRI in the response assessment of colorectal liver metastases after chemotherapy: Correlation between ADC value and histological tumour regression grading.
    Donati F; Boraschi P; Pacciardi F; Cervelli R; Castagna M; Urbani L; Falaschi F; Caramella D
    Eur J Radiol; 2017 Jun; 91():57-65. PubMed ID: 28629572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ferumoxide-enhanced magnetic resonance imaging techniques in pre-operative assessment for colorectal liver metastases.
    van Etten B; van der Sijp J; Kruyt R; Oudkerk M; van der Holt B; Wiggers T
    Eur J Surg Oncol; 2002 Sep; 28(6):645-51. PubMed ID: 12359202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrosis-4 Index, a Noninvasive Fibrosis Marker, Predicts Survival Outcomes After Hepatectomy for Colorectal Cancer Liver Metastases.
    Akiyama T; Miyamoto Y; Imai K; Yamashita Y; Nomoto D; Daitoku N; Sakamoto Y; Kiyozumi Y; Tokunaga R; Eto K; Harada K; Hiyoshi Y; Iwatsuki M; Nagai Y; Iwagami S; Baba Y; Yoshida N; Baba H
    Ann Surg Oncol; 2020 Sep; 27(9):3534-3541. PubMed ID: 32648180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed MRI Enhancement of Colorectal Cancer Liver Metastases Is Associated With Metastatic Mutational Profile.
    Seth A; Amemiya Y; Cheung H; Hsieh E; Law C; Milot L
    Cancer Genomics Proteomics; 2021; 18(5):627-635. PubMed ID: 34479915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prognostic factors for long-term outcome of hepatic resection for colorectal liver metastases].
    Aldrighetti L; Castoldi R; Di Palo S; Arru M; Stella M; Orsenigo E; Gavazzi F; Ferla G; Di Carlo V; Staudacher C
    Chir Ital; 2005; 57(5):555-70. PubMed ID: 16241086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumour subregion analysis of colorectal liver metastases using semi-automated clustering based on DCE-MRI: Comparison with histological subregions and impact on pharmacokinetic parameter analysis.
    Franklin JM; Irving B; Papiez BW; Kallehauge JF; Wang LM; Goldin RD; Harris AL; Anderson EM; Schnabel JA; Chappell MA; Brady M; Sharma RA; Gleeson FV
    Eur J Radiol; 2020 May; 126():108934. PubMed ID: 32217426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic performance of gadoxetic acid-enhanced liver MRI versus multidetector CT in the assessment of colorectal liver metastases compared to hepatic resection.
    Granata V; Fusco R; de Lutio di Castelguidone E; Avallone A; Palaia R; Delrio P; Tatangelo F; Botti G; Grassi R; Izzo F; Petrillo A
    BMC Gastroenterol; 2019 Jul; 19(1):129. PubMed ID: 31340755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors and survival after resection of colorectal liver metastasis in the era of preoperative chemotherapy: an 11-year single-centre study.
    John SK; Robinson SM; Rehman S; Harrison B; Vallance A; French JJ; Jaques BC; Charnley RM; Manas DM; White SA
    Dig Surg; 2013; 30(4-6):293-301. PubMed ID: 23969407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of disappearing lesions after chemotherapy for colorectal liver metastases: Relation between detectability and residual tumors.
    Tani K; Shindoh J; Akamatsu N; Arita J; Kaneko J; Sakamoto Y; Hasegawa K; Kokudo N
    J Surg Oncol; 2018 Feb; 117(2):191-197. PubMed ID: 28876456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-chemotherapeutic CEA and CA19-9 are prognostic factors in patients with colorectal liver metastases treated with hepatic resection after oxaliplatin-based chemotherapy.
    Sakamoto Y; Miyamoto Y; Beppu T; Nitta H; Imai K; Hayashi H; Baba Y; Yoshida N; Chikamoto A; Baba H
    Anticancer Res; 2015 Apr; 35(4):2359-68. PubMed ID: 25862901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resection of colorectal carcinoma liver metastases: A population-based study in outcomes and factors associated with recurrent disease.
    Fenwick A; Black C; Linehan V; Gala-Lopez BL; Costa AF
    Curr Probl Diagn Radiol; 2024; 53(4):481-487. PubMed ID: 38702281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High sensitivity of diffusion-weighted MR imaging for the detection of liver metastases from neuroendocrine tumors: comparison with T2-weighted and dynamic gadolinium-enhanced MR imaging.
    d'Assignies G; Fina P; Bruno O; Vullierme MP; Tubach F; Paradis V; Sauvanet A; Ruszniewski P; Vilgrain V
    Radiology; 2013 Aug; 268(2):390-9. PubMed ID: 23533288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic resonance assessment of sinusoidal obstruction syndrome after neoadjuvant chemotherapy for colorectal liver metastases is not reproducible.
    Staal FC; Beets-Tan RG; Heeres BC; Houwers J; de Boer M; van Dorth D; Lambregts DM; Maas M
    Acta Radiol; 2021 Sep; 62(9):1133-1141. PubMed ID: 32972213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gadoxetic acid-enhanced 3.0 T MR imaging versus multidetector-row CT in the detection of colorectal metastases in fatty liver using intraoperative ultrasound and histopathology as a standard of reference.
    Berger-Kulemann V; Schima W; Baroud S; Koelblinger C; Kaczirek K; Gruenberger T; Schindl M; Maresch J; Weber M; Ba-Ssalamah A
    Eur J Surg Oncol; 2012 Aug; 38(8):670-6. PubMed ID: 22652037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histological response, pattern of tumor destruction and clinical outcome after neoadjuvant chemotherapy including bevacizumab or cetuximab in patients undergoing liver resection for colorectal liver metastases.
    Stremitzer S; Stift J; Singh J; Starlinger P; Gruenberger B; Tamandl D; Gruenberger T
    Eur J Surg Oncol; 2015 Jul; 41(7):868-74. PubMed ID: 25865557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.